Heart Disease Clinical Trials in Dallas

Showing 301-320 of 384 trials

Trial to Compare FFR Measurement With a Non-Side-Hole Guide Catheter Vs. a Side-Hole Guide Catheter

NCT02480569

The investigators propose a single center prospective study that will assess two different strategies for measuring Fractional Flow Reserve (FFR) in patients undergoing clinically-indicated coronary angiography in whom FFR measurement is indicated. FFR will be measured with a non-side hole guide catheter (with the guide catheter both engaged and disengaged from the coronary ostium) and with a side-hole guide catheter (with the guide catheter both engaged and disengaged from the coronary ostium) to determine, whether measurements obtained with an engaged side-hole guide catheter are more accurate as compared with those obtained with the engaged non-side hole catheter.

Coronary Artery Disease

North Texas Veterans Healthcare System25 participantsStarted Jun 2015

Dallas, Texas, United States

COMPLETEDPhase 2< 1 mile

Safety and Tolerability of Initiating LCZ696 in Heart Failure Patients

NCT01922089

The purpose of this study is to assess the safety and tolerability of initiating LCZ696 in heart failure patients with reduced ejection fraction (HF-rEF) using conservative (reaching target dose over 6 weeks) and condensed (reaching target dose over 3 weeks) up-titration regimens.

Heart Failure With Reduced Ejection Fraction

Novartis Pharmaceuticals498 participantsStarted Nov 2013

Anchorage, Alaska, United States • Gilbert, Arizona, United States • Tucson, Arizona, United States +102 more locations

Trial to Compare FFR Measurement With a Non-Side-Hole Guide Catheter Vs. a Side-Hole Guide Catheter

Safety and Tolerability of Initiating LCZ696 in Heart Failure Patients

Heart Disease Trials in Other Cities

TAXUS Libertē Post Approval Study

Multi-center Assessment of Grafts in Coronaries: Long-term Evaluation of the C-Port Device

Does Prophylactic Coronary Artery Revascularization for High Risk Patients Reduce Long-term Risk of Mortality

Aldosterone Antagonist Therapy for Adults With Heart Failure and Preserved Systolic Function

Warfarin Versus Aspirin in Reduced Cardiac Ejection Fraction (WARCEF) Trial

Radial Artery Access With Ultrasound Trial

Type 2 Diabetes Evaluation of Ranolazine in Subjects With Chronic Stable Angina

Niacin Plus Statin to Prevent Vascular Events

GORE Flow Reversal System and GORE Embolic Filter Extension Study

Feasibility Study of BMAC Enhanced CABG

Evaluating the Effectiveness of Sildenafil at Improving Health Outcomes and Exercise Ability in People With Diastolic Heart Failure (The RELAX Study)

Clevidipine in the Treatment of Blood Pressure in Patients With Acute Heart Failure (PRONTO)

A Phase IIb Study to Investigate the Efficacy and Tolerability of Lower Doses Cinaciguat (25 µg/h, 10 µg/h) Given Intravenously to Patients With Acute Decompensated Chronic Congestive Heart Failure (ADHF)

Study of the Effectiveness and Safety of Niaspan ® in the Treatment of Lipid Abnormalities in Latin America

Computed Tomography Dose Reduction Using Sequential or Fast Pitch Sprial Technique

Clinical Evaluation of the Physiological Diagnosis Function in the PARADYM CRT Device

A Pharmacodynamic Study With Ticagrelor in Hispanic Patients

Improving Clinician Communication Skills (ICCS)

Other Conditions in Dallas